Fubing Li
Impact in
- Cancer Research top 10%
- MicroRNA in disease regulation
- Cancer, Hypoxia, and Metabolism
-
- Ubiquitin and proteasome pathways
- Kruppel-like factors research
- Cancer-related gene regulation
- Epigenetics and DNA Methylation
Papers in
-
- Kruppel-like factors research 7
- Cancer-related gene regulation 5
- Epigenetics and DNA Methylation 4
- Ubiquitin and proteasome pathways 4
- Protein Degradation and Inhibitors 3
- Surgery 5
- Orthopedic Infections and Treatments 3
- Orthopedic Surgery and Rehabilitation 3
- Co-authors
- Ceshi Chen (18 shared papers)Zhongmei Zhou (9 shared papers)Yanjie Kong (7 shared papers)Wenlin Chen (3 shared papers)Huichun Liang (5 shared papers)Chunyan Wang (3 shared papers)Rong Liu (2 shared papers)Peiguo Shi (2 shared papers)
- Journals
- Cancer Letters (2 papers)Nuclear Engineering and Technology (1 paper)Cell Death Discovery (1 paper)Cell Death and Disease (1 paper)Journal of Advanced Research (1 paper)
- Partner nations
- ChinaHong KongUnited States
In The Last Decade
Fubing Li
28 papers receiving 781 citations
Peers
Comparison fields: 5 of 91
- Cancer Research 162
- Molecular Biology 544
- Oncology 154
- Genetics 142
- Cell Biology 69
Countries citing papers authored by Fubing Li
This map shows the geographic impact of Fubing Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fubing Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fubing Li more than expected).
Fields of papers citing papers by Fubing Li
This network shows the impact of papers produced by Fubing Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fubing Li. The network helps show where Fubing Li may publish in the future.
Co-authors
The 25 scholars most cited alongside Fubing Li, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 30 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2007 | 115 | |
| 2 | 2017 | 114 | |
| 3 | 2018 | 109 | |
| 4 | 2015 | 71 | |
| 5 | 2019 | 56 | |
| 6 | 2014 | 51 | |
| 7 | 2018 | 48 | |
| 8 | 2014 | 33 | |
| 9 | 2019 | 26 | |
| 10 | 2023 | 22 | |
| 11 | 2021 | 21 | |
| 12 | 2024 | 19 | |
| 13 | 2022 | 19 | |
| 14 | 2024 | 18 | |
| 15 | 2021 | 14 | |
| 16 | 2016 | 13 | |
| 17 | 2021 | 8 | |
| 18 | 2024 | 8 | |
| 19 | [Preparation of cationic vancomycin hydrochloride multivesicular liposomes and its quality]. | 2013 | 4 |
| 20 | 2024 | 3 |
About Fubing Li
Fubing Li is a scholar working on Molecular Biology, Surgery, Oncology, Epidemiology and Genetics, having authored 30 papers that have together received 787 indexed citations. Recurring topics across this work include Kruppel-like factors research (7 papers), Cancer-related gene regulation (5 papers), Epigenetics and DNA Methylation (4 papers), Ubiquitin and proteasome pathways (4 papers), Protein Degradation and Inhibitors (3 papers), Orthopedic Infections and Treatments (3 papers), Orthopedic Surgery and Rehabilitation (3 papers) and Antimicrobial Peptides and Activities (2 papers). The work is most often cited by research in Cancer Research (162 citations), Molecular Biology (544 citations), Oncology (154 citations), Genetics (142 citations) and Cell Biology (69 citations). Fubing Li has collaborated with scholars based in China, Hong Kong and United States. Frequent co-authors include Ceshi Chen, Zhongmei Zhou, Yanjie Kong, Wenlin Chen, Huichun Liang, Chunyan Wang, Rong Liu, Peiguo Shi, Chuanyu Yang and Yingying Wu. Their work appears in journals such as Cancer Letters, Nuclear Engineering and Technology, Cell Death Discovery, Cell Death and Disease and Journal of Advanced Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.